Quick Answer
iHuman Inc. reported Total Revenue of $126.34 million for fiscal year 2024.
iHuman Inc. — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | $126.34M -87.6% |
$1.02B +3.3% |
$985.52M +4.3% |
$944.72M +77.6% |
$531.91M +143.3% |
$218.66M +65.8% |
| Revenue (ASC 606) | $126.34M -87.6% |
$1.02B +3.3% |
$985.52M +4.3% |
$944.72M +77.6% |
$531.91M +143.3% |
$218.66M +65.8% |
| Net Income | $13.51M -92.5% |
$180.91M +64.7% |
$109.82M +396.4% |
-$37.05M +1.1% |
-$37.48M +86.4% |
-$275.60M -1465.5% |
| Diluted EPS | $0.05 -92.4% |
$0.66 +61.0% |
$0.41 +392.9% |
-$0.14 +33.3% |
-$0.21 +86.2% |
-$1.52 |
| Total Assets | $1.42B -2.1% |
$1.45B +8.8% |
$1.33B +21.1% |
$1.10B +5.2% |
$1.05B +522.0% |
$168.31M |
| Cash and Equivalents | $1.12B -7.5% |
$1.21B +15.6% |
$1.05B +22.8% |
$855.36M -0.7% |
$861.68M +721.6% |
$104.88M |
| Stockholders Equity | $131.63M -86.3% |
$957.80M +24.5% |
$769.45M +26.5% |
$608.37M -5.3% |
$642.65M +575.1% |
-$135.27M -112.2% |
| R&D Expense | $247.76M -3.8% |
$257.55M -17.8% |
$313.48M -24.5% |
$415.33M +108.2% |
$199.51M +17.3% |
$170.16M +226.6% |
| Operating Income | $9.85M -93.8% |
$159.89M +43.3% |
$111.58M +305.7% |
-$54.25M -22.0% |
-$44.45M +84.1% |
-$278.81M -1163.7% |
| Gross Profit | $640.15M -11.2% |
$721.27M +4.4% |
$691.17M +4.6% |
$660.62M +80.8% |
$365.44M +171.7% |
$134.49M +103.7% |
| Shares Outstanding | — | — | — | — | — | 215.05M |
- iHuman Inc. reported Total Revenue of $126.34 million for fiscal year 2024.
- iHuman Inc. showed a decrease of -87.6% in Total Revenue compared to the prior fiscal year.
- iHuman Inc. reported Revenue (ASC 606) of $126.34 million for fiscal year 2024.
- iHuman Inc. showed a decrease of -87.6% in Revenue (ASC 606) compared to the prior fiscal year.
- iHuman Inc. reported Net Income of $13.51 million for fiscal year 2024.
- iHuman Inc. showed a decrease of -92.5% in Net Income compared to the prior fiscal year.
- iHuman Inc. reported Diluted EPS of $0.05 per share for fiscal year 2024.
- iHuman Inc. showed a decrease of -92.4% in Diluted EPS compared to the prior fiscal year.
- iHuman Inc. reported Total Assets of $1.42 billion for fiscal year 2024.
- iHuman Inc. showed a decrease of -2.1% in Total Assets compared to the prior fiscal year.
- iHuman Inc. reported Cash and Equivalents of $1.12 billion for fiscal year 2024.
- iHuman Inc. showed a decrease of -7.5% in Cash and Equivalents compared to the prior fiscal year.
- iHuman Inc. reported Stockholders Equity of $131.63 million for fiscal year 2024.
- iHuman Inc. showed a decrease of -86.3% in Stockholders Equity compared to the prior fiscal year.
- iHuman Inc. reported R&D Expense of $247.76 million for fiscal year 2024.
- iHuman Inc. showed a decrease of -3.8% in R&D Expense compared to the prior fiscal year.
- iHuman Inc. reported Operating Income of $9.85 million for fiscal year 2024.
- iHuman Inc. showed a decrease of -93.8% in Operating Income compared to the prior fiscal year.
- iHuman Inc. reported Gross Profit of $640.15 million for fiscal year 2024.
- iHuman Inc. showed a decrease of -11.2% in Gross Profit compared to the prior fiscal year.
- iHuman Inc. reported Shares Outstanding of 215.05 million shares for fiscal year 2019.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: